1. Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low‐risk prostate cancer receiving 5α‐reductase inhibitors. (25th October 2017) Authors: Fradet, Vincent; Toren, Paul; Nguile‐Makao, Molière; Lodde, Michele; Lévesque, Jérome; Léger, Caroline; Caron, André; Bergeron, Alain; Ben‐Zvi, Tal; Lacombe, Louis; Pouliot, Frédéric; Tiguert, Rabi; Dujardin, Thierry; Fradet, Yves Journal: BJU international Issue: Volume 121:Number 3(2018) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗